SCHEMBL26173565

SCHEMBL26173565

CCCC(C)Nc1nc(C)nc(C)c1C(=O)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.43
▸ ALDH1A1 P00352 5/20 0.40
▸ LMNA P02545 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ PKM P14618 1/20 0.40
▸ NPSR1 Q6W5P4 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ PDE4D Q08499 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CRHR1 P34998 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ GMNN O75496 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26173644 0.87 TSHR (0.41) TSHRALDH1A1LMNAKDM4EPKM
SCHEMBL26173638 0.77 HCAR3 (0.33) TSHRALDH1A1LMNAKDM4EPKM
SCHEMBL26124340 0.77 HCAR3 (0.33) TSHRALDH1A1LMNAKDM4EPKM
SCHEMBL31384132 0.77 HCAR3 (0.33) TSHRALDH1A1LMNAKDM4EPKM
SCHEMBL10073316 0.75 PDE4D (0.55) ALDH1A1LMNAKDM4EPKMNPSR1
SCHEMBL26173716 0.73 TSHR (0.38) TSHRALDH1A1LMNAKDM4EPKM
SCHEMBL26173650 0.71 HTR2C (0.40) TSHRALDH1A1LMNAKDM4EPKM
SCHEMBL14725180 0.70 ALDH1A1 (0.58) TSHRALDH1A1LMNAKDM4ENPSR1
SCHEMBL6504933 0.68 KDM4E (0.65) ALDH1A1LMNAKDM4EPKMNPSR1
SCHEMBL12575834 0.68 LMNA (0.51) TSHRALDH1A1LMNAKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104165-A1 PYRIDINE[4,3-D]PYRIMIDINE COMPOUND AS TLR7/8 AGONIST 上海维申医药有限公司 2023-06-15 — — WO disclosed
Send feedback